Remdesivir ‘Significantly Reduced’ CCP Virus in Monkeys: NIH

Remdesivir ‘Significantly Reduced’ CCP Virus in Monkeys: NIH
A vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in March 2020. Gilead Sciences via AP
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:

An experimental drug called remdesivir “significantly reduced” the CCP virus in monkeys, according to a study released on Friday.

The CCP (Chinese Communist Party) virus, a novel coronavirus that emerged from mainland China last year, causes the disease COVID-19. Fears of the spread of the virus has forced the United States into a near-total lockdown, though some states this week announced plans to start reopening soon.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics